Other regulatory molecular mechanisms contributing to the anticancer action of 1,25(OH)D3′s in cervical cancer cells include the downregulation of oncogenic voltage channels [52], upregulation of DDX5 RNA helicase action [58], and increased biogenesis of microRNAs regulating cancer pathways [59]. The gene discussed is DDX5; the disease is cervical cancer.